3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
41
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Neoplasm Metastasis
7
Uterine Cervical Neoplasms
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Paclitaxel
5
Carboplatin
3
Taxes
2
Specimen Handling
2
Nivolumab
2
Biopsy
2
rucaparib
1
rebastinib
1
pembrolizumab
1
olaparib
1
durvalumab
1
cediranib
1
capivasertib
1
cabozantinib
1
Magnetic Resonance Spectroscopy
1
LY-2157299
1
Immunoglobulin G
1
Ifosfamide
1
Fluid Therapy
1
Disulfides
1
DCC-2036
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinosarcoma
×
atezolizumab
×
Clear all
No trials found.